Physician

Omran Riad Abul-Khoudoud, MD, FACS, RVT

According to 2025 Medicare claims, Omran Abul-Khoudoud, MD, FACS, RVT (NPI: 1083664254) practices vascular surgery in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Greenup, KY. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC. (NPI: 1134484892; TIN: 264183569) and primary practice location at 41101-2843.

Abul-Khoudoud's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 928 traditional Medicare patients, billed 2,833 HCPCS/CPT codes, and received $296,024 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 291 prescription claims across 147 beneficiaries totaling $17,858 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 11 claims. Open Payments data shows 16 records totaling $508. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $768,719 to $296,024. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $28,582 and ending at $17,858. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,214 to $2,362.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,908	6,777	$768,719
2016	1,769	6,320	$757,062
2017	1,961	5,701	$704,225
2018	2,000	6,128	$840,353
2019	1,792	5,735	$673,025
2020	1,315	4,262	$509,263
2021	1,253	4,067	$439,811
2022	1,131	3,620	$394,856
2023	1,016	3,019	$318,060
2024	928	2,833	$296,024

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	320	981	$28,582
2016	334	1,083	$36,593
2017	354	1,091	$44,920
2018	292	765	$47,610
2019	248	546	$32,748
2020	220	501	$46,373
2021	234	494	$30,761
2022	207	401	$46,388
2023	190	382	$51,804
2024	147	291	$17,858

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	23	29	$21,114
2019	N/R	11	$457
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	242	280	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	222	277	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	168	189	$61
93922	Ultrasound study of arm and leg arteries	229	306	$39
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	115	148	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	15	570	$11,181
Warfarin Sodium	Warfarin Sodium	38	2,700	$369
Cilostazol	Cilostazol	18	930	$278
Clopidogrel	Clopidogrel Bisulfate	39	1,710	$262
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	85	165	$187

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$508	ShockWave Medical, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Omran Riad Abul-Khoudoud, MD, FACS, RVT?

Tedicare shows public-source Medicare data for Omran Riad Abul-Khoudoud, MD, FACS, RVT (NPI 1083664254), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Omran Riad Abul-Khoudoud, MD, FACS, RVT have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Omran Riad Abul-Khoudoud, MD, FACS, RVT?

Omran Riad Abul-Khoudoud, MD, FACS, RVT is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC. (billing NPI 1134484892) in the available physician profile data.

Does Omran Riad Abul-Khoudoud, MD, FACS, RVT have Open Payments data?

Omran Riad Abul-Khoudoud, MD, FACS, RVT has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.